Announcing the appointment of Associate Professor Ravindran Kanesvaran as Co-Director of the STCC
Ravindran Kanesvaran shared a post by Consortium for Clinical Research and Innovation, Singapore on LinkedIn:
“The Singapore Translational Cancer Consortium (STCC) is a collaborative initiative enhancing cancer research across Singapore, fostering national partnerships, and joining global networks like Roche’s imCORE.
Its projects, such as Project CADENCE, advance precision oncology by promoting early cancer detection and personalized treatments. STCC’s development of national databases and tissue banks further supports cutting-edge research.
I am deeply grateful and honored to be named as co-director of STCC and help Exec Director Professor Wee Joo Chng in leading this wonderful organisation. I look forward to contributing to its mission of pioneering impactful cancer research and improving outcomes for patients in Singapore and beyond.
Would also like to thank Professor Soon Thye Lim for his impactful contribution to STCC over the past 5 years . ”
Quoting Consortium for Clinical Research and Innovation, Singapore’s post:
“It is our pleasure to announce the appointment of Associate Professor Ravindran Kanesvaran as Co-Director of the Singapore Translational Cancer Consortium (STCC).
Associate Professor Ravindran will succeed Professor Soon Thye LIM who has served STCC as its Co-Director since November 2019. We extend our heartfelt gratitude to Professor Lim for his excellent contributions to the formation, development, and growth of STCC over the past five years.
Associate Professor Ravindran is actively involved in clinical research and is a key opinion leader globally in both genitourinary cancers and geriatric oncology. He has published over 240 peer reviewed manuscripts in leading cancer journals.
Associate Professor Ravindran is Chairman of the Division of Medical Oncology, National Cancer Centre Singapore, where he also chairs the Office of Population Health at NCCS.
He is also an Associate Professor at Duke-NUS Medical School and Distinguished Professor of Geriatric Oncology at the school. He is also currently the Vice-Chairman of the Singapore Cancer Society.
Together with Executive Director STCC, Prof Wee Joo Chng, Associate Professor Ravindran will continue the key initiatives of STCC, which include the formation of multidisciplinary tumour groups to catalyse research proposals, the coordination of translational and preclinical research projects through a centralised pipeline, and the development of a tumour model catalogue.
Welcome, Associate Professor Ravindran!
Dr. Ravindran Kanesvaran is the Chairman of the Division of Medical Oncology at the National Cancer Centre Singapore and a Professor of Geriatric Oncology at Duke-NUS Medical School. He also holds the position of Associate Professor at Duke-NUS, where he is involved in teaching and research. His research interests include genito-urinary oncology and geriatric oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023